<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 2.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8" />
	<meta name="description" content="Homepage for Group of Professor Fei Wang, Department of Population Health Sciences, Weill Cornell Medicine Colledge" />
	<meta name="keywords" content="Machine Learning for Healthy Data" />
	<meta name="Homepage for Group of Professor Fei Wang" content="Research" />
	<link rel="stylesheet" type="text/css" href="../../Hao.css" title="Basic Profile" media="all" />
	<title>AAAI 2021 Tutorial on AI for COVID-19: Battling the Pandemic with Computational Intelligence</title>
</head>

<body>
	
	
	<!--style="font-family: Calibri; color: blue; text-decoration: underline;"-->

	<div id="content">
		<!--<h2>What Starts Here Changes The World!</h2>-->
		<br>
			
		<h1>KDD 2025 Workshop on PharmKDD: Knowledge Discovery and Data Mining for Pharmaceutical Research and Development</h1>
		
		<h2>A <a href="https://kdd2025.kdd.org/">KDD 2025</a> Workshop</h2>
		
		<br>
		<br>
		
		<font style="font-weight: bold">Presenter: Fei Wang</font>
		<br>
		<br>
		
		Pharmaceutical research and development (PRD) refers to the process of discovering and developing medicines and treatments. 
		It is an expensive ($1-2.6 billion on average) and time consuming (10-15 years on average)  process. Despite the time and monetary 
		investments, historical data shows that the success rate of a new drug from discovery to final approval from the Food and Drug 
		Administration is only around 10%. This fact highlights the urgent need for innovative methods to improve the efficiency and success 
		rate of the PRD process.<br>


		There are many steps in the PRD pipeline, which includes target identification, molecule design and synthesis, pre-clinical development, 
		human clinical trials, and post-marketing surveillance. Over the years, large volumes of data have been accumulated from these different 
		steps, which encode evidence and insights of the PRD process. This provides an unprecedented opportunity for developing effective data 
		mining and knowledge discovery (KDD) methods to extract insights from those data to improve the PRD process. Furthermore, advances in 
		deep phenotyping using AI have greatly expanded the disease landscape, capturing a richer spectrum of disease attributes and patient 
		subtypes, which in turn elevates drug discovery efforts by refining target identification and validation—effectively transforming the 
		other side of the therapeutic equation into a more precise, data-driven realm of innovation.<br>


		There are lots of examples of recent research developing KDD methods for PRD. For example, AlphaFold, won the Nobel Prize in chemistry 
		in 2024. However, the existing research has been mostly isolated into different communities 
		focusing on a particular intermediate step, while we cannot have any of these steps fail in order to successfully develop a drug. 
		Therefore, there is an urgent need for a forum to bring together researchers and practitioners from both academia and industry working 
		on different aspects of KDD for PRD, discuss the state-of-the-art research and technologies, and chart the future agenda.<br>

		
		<br>
		
		The outline of the entire tutorial is listed below. <br>
		
		<br>
		
		<ul style="margin-left: 30px">
			
		<li> Introduction (10 min, <a style=" color: blue;" href="https://www.dropbox.com/s/6gqnjhtl2nkwen6/Part1_Fei_COVID_Introduction.pdf?dl=0">Slides</a>)</li>
		
		<li> Epidemiology (35 min, <a style=" color: blue;" href="https://www.dropbox.com/s/3mgekbfgpu8xl2q/Part2_Fei_COVID_Epidemiology.pdf?dl=0">Slides</a>)</li>
			<li style="margin-left:2em"> Compartment Models </li>
			<li style="margin-left:2em"> Machine Learning for Compartment Models </li>
			<li style="margin-left:2em"> Estimating the Impact of Non-Pharmaceutical Interventions </li>
			<li style="margin-left:2em"> Knowledge Transfer </li>
			<li style="margin-left:2em"> Estimating the Impact of Temperature and Relative Humidity </li>
			
		<li> Therapeutics (25 min, <a style=" color: blue;" href="https://www.dropbox.com/s/o75xsjymjosds98/Part3_Fei_COVID_Therapeutics.pdf?dl=0">Slides</a>)</li>
			<li style="margin-left:2em"> De-Novo Design </li>
			<li style="margin-left:2em"> Computational Drug Repurposing </li>
			<li style="margin-left:2em"> Knowledge Graph </li>
			
		<li> Clinical Research (75 min, <a style=" color: blue;" href="https://www.dropbox.com/s/rjl9bcj0x0e1wwn/Part4_Fei_COVID_Clinical.pdf?dl=0">Slides</a>)</li>
			<li style="margin-left:2em"> Image Based Diagnosis and Prognosis </li>
			<li style="margin-left:2em"> Prediction of Infection Status with Rountined Blood Tests </li>
			<li style="margin-left:2em"> Prediction of Clinical Severity with EHR </li>
			<li style="margin-left:2em"> Deep Phenotyping with Clinical Information at Patient Admission </li>
			<li style="margin-left:2em"> Progression Subphenotyping of Intubated Patients </li>
			
		<li> Behavioral and Social Sciences (25 min, <a style=" color: blue;" href="https://www.dropbox.com/s/w6ewf21ymsqy79c/Part5_Fei_COVID_Behavioral.pdf?dl=0">Slides</a>)</li>
			<li style="margin-left:2em"> Information Search Behavior Change </li>
			<li style="margin-left:2em"> The Impact of Misinformation </li>
			<li style="margin-left:2em"> Psychosocial Impacts </li>
			<li style="margin-left:2em"> Mobility Network </li>
			<li style="margin-left:2em"> Contact Tracing </li>
			
		<li> Conclusions (10 min, <a style=" color: blue;" href="https://www.dropbox.com/s/8jb09pr5c3hqfys/Part6_Fei_COVID_Conclusion.pdf?dl=0">Slides</a>)</li>
			
		</ul>
		<br>
		
		References <br>
		
		<br>
		
		<ul style="margin-left: 30px">
			
			<li>Ted T. Ashburn and Karl B. Thor. "Drug repositioning: identifying and developing new uses for existing drugs." Nature reviews Drug discovery 3, no. 8 (2004): 673-683.</li>
			
			<li>Ana I. Bento, Thuy Nguyen, Coady Wing, Felipe Lozano-Rojas, Yong-Yeol Ahn, and Kosali Simon. "Evidence from internet search data shows 
				information-seeking responses to news of local COVID-19 cases." Proceedings of the National Academy of Sciences 117, no. 21 (2020): 11220-11222.</li>
			
			<li>Leonardo Bursztyn, Aakaash Rao, Christopher Roth, and David Yanagizawa-Drott. "Misinformation during a pandemic." University of Chicago, 
				Becker Friedman Institute for Economics Working Paper 2020-44 (2020).</li>

			
			<li>Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza F. Abrahão, Amanda Alberga et al. 
				"Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study." Nature communications 11, 
				no. 1 (2020): 1-11.</li>
			<li>Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky, and Jure Leskovec. "Mobility network models of 
				COVID-19 explain inequities and inform reopening." Nature (2020): 1-6.</li>
			
			<li>Kun Chen and Fei Wang. "Discussion on “The timing and effectiveness of implementing mild interventions of COVID-19 in large industrial 
				regions via a synthetic control method” by Tian et al." Statistics and Its Interface 14, no. 1 (2021): 15-17.</li>
			
			<li>Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, Helia Sanchez et al. "Network medicine framework 
				for identifying drug repurposing opportunities for covid-19." arXiv preprint arXiv:2004.07229 (2020).</li>
			
			<li>Tongtong Huang, Yan Chu, Shayan Shams, Yejin Kim, Genevera Allen, Ananth V. Annapragada, Devika Subramanian, Ioannis Kakadiaris, 
				Assaf Gottlieb, and Xiaoqian Jiang. "Population stratification enables modeling effects of reopening policies on mortality and 
				hospitalization rates." arXiv preprint arXiv:2008.05909 (2020).</li>
			
			<li>Rainu Kaushal, George Hripcsak, Deborah D. Ascheim, Toby Bloom, Thomas R. Campion Jr, Arthur L. Caplan, Brian P. Currie et al. 
				"Changing the research landscape: the new York City clinical data research network." Journal of the American Medical Informatics 
				Association 21, no. 4 (2014): 587-590.</li>
			
			<li>Yingxue Li, Wenxiao Jia, Junmei Wang, Jianying Guo, Qin Liu, Xiang Li, Guotong Xie, and Fei Wang. "ALeRT-COVID: Attentive 
				Lockdown-awaRe Transfer Learning for Predicting COVID-19 Pandemics in Different Countries." Journal of healthcare informatics 
				research (2020): 1-16.</li>
			
			<li>Wenhua Liang, Hengrui Liang, Limin Ou, Binfeng Chen, Ailan Chen, Caichen Li, Yimin Li et al. "Development and validation of 
				a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19." JAMA Internal 
				Medicine (2020).</li>
			
			<li>Wenhua Liang, Jianhua Yao, Ailan Chen, Qingquan Lv, Mark Zanin, Jun Liu, SookSan Wong et al. "Early triage of critically ill 
				COVID-19 patients using deep learning." Nature communications 11, no. 1 (2020): 1-7.</li>
			
			<li>Xiaoshuang Liu, Xiao Xu, Guanqiao Li, Xian Xu, Yuyao Sun, Fei Wang, Xuanling Shi, Xiang Li, Guotong Xie, and Linqi Zhang. 
				“Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States.” BMC Public Health. 2021.</li>
			
			<li>Xueyan Mei, Hao-Chih Lee, Kai-yue Diao, Mingqian Huang, Bin Lin, Chenyu Liu, Zongyu Xie et al. "Artificial intelligence–enabled 
				rapid diagnosis of patients with COVID-19." Nature Medicine (2020): 1-5.</li>
			<li>Nadeem Ahmed, Regio A. Michelin, Wanli Xue, Sushmita Ruj, Robert Malaney, Salil S. Kanhere, Aruna Seneviratne, Wen Hu, Helge Janicke, and Sanjay K. Jha. 
				"A survey of covid-19 contact tracing apps." IEEE Access 8 (2020): 134577-134601.</li>
			
			<li>Jerry M. Parks and Jeremy C. Smith. "How to discover antiviral drugs quickly." New England Journal of Medicine 382, no. 23 (2020): 2261-2264.</li>
			
			<li>Alexander Rodriguez, Anika Tabassum, Jiaming Cui, Jiajia Xie, Javen Ho, Pulak Agarwal, Bijaya Adhikari, and B. Aditya Prakash. 
				"DeepCOVID: An Operational Deep Learning-driven Framework for Explainable Real-time COVID-19 Forecasting." medRxiv (2020).</li>
				
			<li>Koustuv Saha, John Torous, Eric D. Caine, and Munmun De Choudhury. "Psychosocial Effects of the COVID-19 Pandemic: 
				Large-scale Quasi-Experimental Study on Social Media." Journal of medical Internet research 22, no. 11 (2020): e22600.</li>
				
			<li>Benjamin Sanchez-Lengeling and Alán Aspuru-Guzik. "Inverse molecular design using machine learning: Generative models for matter engineering." 
				Science 361, no. 6400 (2018): 360-365.</li>
			
			<li>Chang Su, Zhenxing Xu, Katherine Hoffman, Parag Goyal, Monika M Safford, Jerry Lee, Sergio Alvarez-Mulett, Luis Gomez-Escobar, David R Price, 
				John S Harrington, Lisa K Torres, Fernando J Martinez, Thomas R Campion, Rainu Kaushal, Augustine MK Choi, Fei Wang, Edward J Schenck. "Identifying organ 
				dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19." medRxiv (2020).</li>
			
			<li>Ting Tian, Wenxiang Luo, Jianbin Tan, Yukang Jiang, Minqiong Chen, Wenliang Pan, Songpan Yang, Jiashu Zhao, Xueqin Wang, and Heping Zhang. 
				"The timing and effectiveness of implementing mild interventions of COVID-19 in large industrial regions via a synthetic control method." 
				Statistics and Its Interface 14, no. 1 (2021): 3-12.</li>
			
			<li>Akhil Vaid, Suraj K Jaladanki, Jie Xu, Shelly Teng, Arvind Kumar, Samuel Lee, Sulaiman Somani, Ishan Paranjpe, Jessica K De Freitas, 
				Tingyi Wanyan, Kipp W Johnson, Mesude Bicak, Eyal Klang, Young Joon Kwon, Anthony Costa, Shan Zhao, Riccardo Miotto, Alexander W Charney, 
				Erwin Böttinger, Zahi A Fayad, Girish N Nadkarni, Fei Wang, Benjamin S Glicksberg. "Federated learning of electronic health records improves 
				mortality prediction in patients hospitalized with covid-19." JMIR Medical Informatics. 2021.</li>
			
			<li>Jay J. Van Bavel, Katherine Baicker, Paulo S. Boggio, Valerio Capraro, Aleksandra Cichocka, Mina Cikara, Molly J. Crockett et al. 
				"Using social and behavioural science to support COVID-19 pandemic response." Nature human behaviour 4, no. 5 (2020): 460-471.</li>
			
			<li>Jingyuan Wang, Ke Tang, Kai Feng, Xin Lin, Weifeng Lv, Kun Chen, and Fei Wang. "Impact of Temperature and Relative Humidity on the Transmission 
				of COVID-19: A Modeling Study in China and the United States." BMJ Open 2021.</li>
			
			<li>Qingyun Wang, Manling Li, Xuan Wang, Nikolaus Parulian, Guangxing Han, Jiawei Ma, Jingxuan Tu et al. "Covid-19 literature knowledge 
				graph construction and drug repurposing report generation." arXiv preprint arXiv:2007.00576 (2020).</li>
			
			<li>Ross D. Williams, Aniek F. Markus, Cynthia Yang, Talita Duarte Salles, Scott L. Duvall, Thomas Falconer, Jitendra Jonnagaddala et al. 
				"Seek COVER: Development and validation of a personalized risk calculator for COVID-19 outcomes in an international network." medRxiv (2020).
			</li>
			
			<li>Chen Yang, Xinyi Zhou, and Reza Zafarani. "CHECKED: Chinese COVID-19 Fake News Dataset." arXiv preprint arXiv:2010.09029 (2020).</li>
			
			<li>He Sarina Yang, Yu Hou, Ljiljana V Vasovic, Peter Steel, Amy Chadburn, Sabrina E Racine-Brzostek, Priya Velu, Melissa Cushing, Massimo Loda, 
				Rainu Kaushal, Zhen Zhao and Fei Wang. "Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning." 
				Clinical chemistry 66, no. 11 (2020): 1396-1404.</li>
			
			<li>He Sarina Yang, Yu Hou, Hao Zhang, Amy Chadburn, Lars F Westblade, Richard Fedeli, Peter AD Steel, Sabrina E Racine-Brzostek, Priya Velu, 
				Jorge L Sepulveda, Michael J Satlin, Melissa M Cushing, Rainu Kaushal, Zhen Zhao and Fei Wang. "Machine learning analysis highlights 
				the down-trending of the proportion of COVID-19 patients with a distinct laboratory result profile." medRxiv (2020).</li>
			
			<li>Chengxi Zang, and Fei Wang. "MoFlow: an invertible flow model for generating molecular graphs." In Proceedings of the 26th ACM SIGKDD International 
				Conference on Knowledge Discovery & Data Mining, pp. 617-626. 2020.</li>
			
			<li>Xiangxiang Zeng, Xiang Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, Zheng Zhang, Kenli Li, George Karypis, and Feixiong Cheng. 
				"Repurpose open data to discover therapeutics for COVID-19 using deep learning." Journal of proteome research 19, no. 11 (2020): 
				4624-4636.</li>
			
			<li>Kang Zhang, Xiaohong Liu, Jun Shen, Zhihuan Li, Ye Sang, Xingwang Wu, Yunfei Zha et al. "Clinically applicable AI system for 
				accurate diagnosis, quantitative measurements, and prognosis of covid-19 pneumonia using computed tomography." Cell (2020).</li>

			
			<li>Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper, Mark S. Veselov, Vladimir A. Aladinskiy, Anastasiya V. Aladinskaya, Victor A. Terentiev et al. 
				"Deep learning enables rapid identification of potent DDR1 kinase inhibitors." Nature biotechnology 37, no. 9 (2019): 1038-1040.</li>
			
			<li>Alex Zhavoronkov, Bogdan Zagribelnyy, Alexander Zhebrak, Vladimir Aladinskiy, Victor Terentiev, Quentin Vanhaelen, Dmitry S. Bezrukov et al. 
				"Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal 
				chemist in virtual reality". ChemRxiv (2020).</li>
			
			<li>Yadi Zhou, Fei Wang, Jian Tang, Ruth Nussinov, and Feixiong Cheng. "Artificial intelligence in COVID-19 drug repurposing." 
				The Lancet Digital Health. 2020 Dec;2(12):e667-e676.</li>
			
			<li>Xinyi Zhou, Apurva Mulay, Emilio Ferrara, and Reza Zafarani. "ReCOVery: A Multimodal Repository for COVID-19 News Credibility 
				Research." arXiv preprint arXiv:2006.05557 (2020).</li>

			
			<li>Difan Zou, Lingxiao Wang, Pan Xu, Jinghui Chen, Weitong Zhang, and Quanquan Gu. "Epidemic model guided machine learning for COVID-19 forecasts 
				in the United States." medRxiv (2020).</li>
			
			
	                    		
		</ul>
		<p class="credits">&copy; Fei Wang <br />
		</ul>
		
		
	</div>

</body>
</html>
